ARTICLE | Clinical News
RotaShield: Completed Phase II enrollment
January 25, 2010 8:00 AM UTC
The non-profit organization completed enrollment of 998 infants in a double-blind, placebo-controlled, African Phase II trial evaluating oral RotaShield given once soon after birth and again 60 days l...